Addition of Phytosterols to a Low Phytosterol Diet (phyteaux-I)

April 17, 2012 updated by: Richard E. Ostlund Jr., MD, Washington University School of Medicine

Regulation of Cholesterol Absorption: Dose Response of LDL to Phytosterols Added to a Phytosterol-Poor Diet

Studies have shown that phytosterols will lower LDL cholesterol. Typical diets can contain between 250 to 500 mg of naturally-occurring phytosterols. Long-term studies with phytosterol-containing products(such as margarines) have not taken into account the amounts of naturally occurring phytosterols in the diet. This means that the effects of small amounts of natural dietary phytosterols on LDL cholesterol are not known. In this study, we will examine the effects of phytosterols across a range of levels. The information will likely be used to further support and possibly extend the current dietary recommendations for phytosterol use.

Study Overview

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Louisiana
      • Baton Rouge, Louisiana, United States, 70808
        • Pennington Biomedical Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Men and women are eligible who:

  • are of any race or ethnicity between 18 to 80 years of age;
  • are in generally good health;
  • have moderately elevated blood cholesterol(LDL cholesterol between 100 and 189 mg/dl)
  • will eat only the foods that are provided by the center during the diet periods;
  • will drink no more than 5 cups of caffeine-containing beverages a day;
  • will consume no more than 1 alcoholic drink a day;
  • will abstain from the consumption of alcohol for 48-hours prior to blood draw days

Exclusion Criteria:

  • are younger than 18 or older than 80 years;
  • have very high cholesterol(LDL cholesterol equal to or above 190 mg/dl or triglycerides equal to or above 250 mg/dl);
  • have very high blood pressure(equal to or above 160 mm Hg systolic or 95 mm Hg diastolic);
  • are overweight( BMI greater than 35 kg/m2)
  • are taking lipid-lowering, or any other medication known to affect blood cholesterol;
  • have diabetes mellitus, cancer, heart, liver and/or kidney disease, or chronic disease that might interfere with participation;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Medium Phytosterols
Diets with daily 400 mg of phytosterols
Diets with 59, 400, or 2000 mg of phytosterols daily for 4 weeks were given to each subject, in random order.
Experimental: High Phytosterols Diet
Diet with 2000 mg of daily phytosterols
Diets with 59, 400, or 2000 mg of phytosterols daily for 4 weeks were given to each subject, in random order.
Placebo Comparator: Low Phyto Diet
Diet with less than 100 mg of daily phytosterols
Diets with 59, 400, or 2000 mg of phytosterols daily for 4 weeks were given to each subject, in random order.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Fecal cholesterol excretion
Time Frame: At the end of week 4 on each diet
At the end of week 4 on each diet

Secondary Outcome Measures

Outcome Measure
Time Frame
intestinal cholesterol absorption
Time Frame: At the end of week 4 on each diet
At the end of week 4 on each diet

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Richard Ostlund, MD, Washington University School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2006

Primary Completion (Actual)

September 1, 2006

Study Completion (Actual)

October 1, 2008

Study Registration Dates

First Submitted

March 10, 2009

First Submitted That Met QC Criteria

March 10, 2009

First Posted (Estimate)

March 11, 2009

Study Record Updates

Last Update Posted (Estimate)

April 19, 2012

Last Update Submitted That Met QC Criteria

April 17, 2012

Last Verified

April 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypercholesterolemia

3
Subscribe